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Background:  The role of impaired coagulation process in atherogenesis and its clinical manifestations is well established. In addition, the role of 
the genetic variability on fibrinogen beta chain gene on fibrinogen levels is widely speculated. In the present study we sought to examine whether a 
single nucleotide polymorphism could affect the coagulation cascade beyond its effect on fibrinogen.
Methods:  The study population consisted of 318 patients with documented coronary artery disease (CAD) and 221 controls. The G455A 
polymorphism was estimated by polymerase chain reaction (PCR) and the specific HaeIII restriction enzyme. Serum levels of D-dimers, factor (f) V, 
factor (f) X were measured by standard coagulometry techniques.
Results:  The genotype distribution was GG: 49.3%, GA: 41.2%, AA: 9.5% for CAD and GG: 55.2%, GA: 35.7%, AA: 9.1% for controls. Through 
the study (overall) population the G455A polymorphism affected significantly D-dimers levels (μg/l) between the G allele carriers and the AA 
homozygotes (median: 2.55[2.37-2.71] vs 2.68[2.38-2.83], p<0.05), as well as fV (%) (114.6±24.7 vs 126.8±26.6). No effect was observed 
on fX levels (p=NS). Moreover, there was no significant difference in the studied parameters across the genotypes in the control group (p=NS for 
all). Controversially to the control group, the G455A polymorphism defined D-dimers and fX and fV levels in CAD patients. More specifically, the 
AA homozygosity was associated with significant increased levels of D-dimers (median: 2.75[2.50-2.90] vs 2.60[2.40-2.70]), fV (135.0±20.5 vs 
119.5±24.8) and fX (102.4±19.6 vs 90.1±22.8) compared to the G allele carriers (p<0.05 for all).
Conclusion: A single nucleotide polymorphism on beta chain fibrinogen gene, regulates D-dimers, factor V and factor X levels in patients with 
advanced atherosclerosis. Our findings indicate that the G455A polymorphism may affect the coagulation, a responsible underlying mechanism for 
atherogenesis and this is beyond its effect on fibrinogen.
